Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
PHASE1CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
August 31, 2001
Conditions
Lung Cancer
Interventions
DRUG
carboplatin
DRUG
paclitaxel
DRUG
tipifarnib
RADIATION
radiation therapy
Trial Locations (1)
19104-4283
Abramson Cancer Center of the University of Pennsylvania, Philadelphia
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Abramson Cancer Center at Penn Medicine
OTHER
NCT00025480 - Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter